Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04352777
Title Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Duke University

Her2-receptor negative breast cancer


Abemaciclib + Letrozole

Abemaciclib + Anastrozole

Abemaciclib + Fulvestrant

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.